Australia is welcome innovative treatment for weight issues: Retatrutide. This dual compound – targeting on both GLP-1 and GIP receptors – has promising outcomes in global research, suggesting considerable reductions in BMI. While regulatory clearance hasn't occurred with Australian regulators, a number of individuals struggling obesity are vie… Read More